Bio-Rad Laboratories has completed the acquisition of all equity interests in Stilla Technologies, a French corporation, as of June 30, 2025. This finalizes a binding offer first announced in February 2025, marking the official integration of Stilla's technology into Bio-Rad's portfolio.
